Research map: Letter: The Microbiome‐Mediated Impact of Proton Pump Inhibitors on Spontaneous Bacterial Peritonitis

Back to the article

Papers in this map

  1. AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review · Laura E. Targownik · 2022 · 315 citations · Cited by this paper
  2. Letter: The Microbiome‐Mediated Impact of Proton Pump Inhibitors on Spontaneous Bacterial Peritonitis—Authors' Reply · Lukas Sturm · 2026 · Cites this paper
  3. Review Article: Biomarkers in Liver Transplantation for Hepatocellular Carcinoma: Towards Precision Medicine · 2026 · Related
  4. Implementation of a proton pump inhibitor stewardship program · Kelly W. Davis · 2017 · 17 citations · Cited by this paper
  5. Letter: External Validation of Hepcidin Thresholds for Predicting Response to Iron Therapy in Active Inflammatory Bowel Disease · 2026 · Related
  6. Altered Pathogen Spectrum of Spontaneous Bacterial Peritonitis in Patients Treated With Proton Pump Inhibitors · P J Kitchen · 2026 · 6 citations · Cited by this paper
  7. Development and Validation of a Machine Learning Model to Prognosticate Hepatocellular Carcinoma · 2026 · Related
  8. Natural History of Recurrent Acute Pancreatitis: Implications for Interventional Trial Design · 2026 · Related
  9. Letter: Low FODMAP Therapy in Paediatric Irritable Bowel Syndrome: Balancing Efficacy, Expectancy and Safety · 2026 · Related
  10. Letter: Does the Association Between Mild Endoscopic Activity and Adverse Outcomes Justify Treatment Escalation in Older Adults With Inflammatory Bowel Disease? · 2026 · Related
  11. Eosinophilic Oesophagitis Beyond the Oesophagus: High Prevalence of Chronic Rhinosinusitis‐Type Symptoms and Their Impact on Symptom Severity in Swiss EoE Cohort Study Patients · 2026 · Related
  12. Non‐Selective Beta‐Blocker Use Is Associated With Lower Mortality After Decompensation in Cirrhosis: A Nationwide Target Trial Emulation · 2026 · Related
  13. Clinical Trial: Phase 3 Trial of Resmetirom Versus Placebo in Metabolic Dysfunction‐Associated Steatohepatitis—Reanalysis of Fibrosis Stage 2–3 Subset · 2026 · Related
  14. Clinical Outcomes After Percutaneous Coronary Intervention in Patients With Cirrhosis: A Multicentre National Study · 2026 · Related

Source: OpenAlex (CC0)